id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2003-P-0124-0003,FDA,FDA-2003-P-0124,Acknowledgment Letter from FDA DMB to Worldclient,Other,Acknowledgement Letter/Receipt,2003-12-12T05:00:00Z,2003,12,2003-12-12T05:00:00Z,,2024-11-18T19:38:46Z,,0,0,0900006480485f72
FDA-2003-P-0124-0002,FDA,FDA-2003-P-0124,Petition Denial from FDA CDRH to Chemically Associated Neurological Disorders,Other,PDN-Petition Denial,2003-12-05T05:00:00Z,2003,12,2003-12-04T05:00:00Z,,2024-11-18T19:11:20Z,,0,0,0900006480485f63
FDA-2003-P-0124-0001,FDA,FDA-2003-P-0124,Acknowledgment Letter from FDA DMB to Chemically Associated Neurological Disorders,Other,ACK-Acknowledgement Letter,2003-11-19T05:00:00Z,2003,11,2003-11-18T05:00:00Z,,2024-11-19T02:00:45Z,,0,0,0900006480485eb9